PO
Poolbeg Pharma PLC
POLBF · OTC
$0.10 +0.00% (+$0.00)
Market Cap £54.7M
P/E Ratio -
Div. Yield -
ROE 53.90%
Piotroski F-Score Weak
1/9Valuation
20 /100
Expensive P/B 6.36x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 22.29%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 73.60%
ROE 53.90%
ROA 57.28%
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 6.17x
Int. coverage N/A
Stability
27 /100
Unstable Beta 1.81x
EPS volatility 37.15%
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na POLBF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jeremy Skillington
Employees
15
Headquarters
London
Nadcházející události
04 BŘE
Earnings
Upcoming earnings report